Atle Fund Management AB 13F 持仓 · 2026年Q2
Atle Fund Management AB 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 39 只证券，申报市值合计 3.72 亿美元。前几大持仓：LLY（9.62%）、MRK（6.55%）、JNJ（5.84%）。本季前 25 大持仓中：新建仓 1 只、增持 12 只、减持 12 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & CO | $35.8M | 9.62% | 29,821 | 减持 |
| 2 | MRK | MERCK & CO. INC | $24.3M | 6.55% | 189,357 | 增持 |
| 3 | JNJ | JOHNSON & JOHNSON | $21.7M | 5.84% | 85,425 | 减持 |
| 4 | ABBV | ABBVIE INC | $16.2M | 4.35% | 64,325 | 减持 |
| 5 | CVS | CVS HEALTH CORP | $15.1M | 4.07% | 146,102 | 增持 |
| 6 | TMO | THERMO FISHER SCIENTIFIC CORP | $14.0M | 3.76% | 27,859 | 增持 |
| 7 | RVMD | REVOLUTION MEDICINES INC | $13.7M | 3.68% | 73,077 | 减持 |
| 8 | BIIB | BIOGEN INC | $13.6M | 3.65% | 62,781 | 新建仓 |
| 9 | NBIX | NEUROCRINE BIOSCIENCES INC | $12.3M | 3.31% | 72,898 | 减持 |
| 10 | MIRM | MIRUM PHARMACEUTICALS INC | $11.8M | 3.17% | 100,807 | 减持 |
| 11 | ALKS | ALKERMES PLC | $11.2M | 3.01% | 213,329 | 减持 |
| 12 | IONS | IONIS PHARMACEUTICALS INC | $10.9M | 2.93% | 137,131 | 增持 |
| 13 | ONC | BEONE MEDICINES LTD-ADR | $10.0M | 2.70% | 35,180 | 减持 |
| 14 | ISRG | INTUITIVE SURGICAL INC | $9.8M | 2.64% | 24,656 | 减持 |
| 15 | SYK | STRYKER CORPORATION | $9.5M | 2.57% | 30,283 | 增持 |
| 16 | VRTX | VERTEX PHARMACEUTICALS INC | $9.5M | 2.56% | 19,131 | 减持 |
| 17 | EW | EDWARDS LIFESCIENCES CORP | $9.3M | 2.51% | 103,230 | 减持 |
| 18 | BBIO | BRIDGEBIO PHARMA INC | $9.3M | 2.50% | 124,707 | 增持 |
| 19 | KRYS | KRYSTAL BIOTECH, INC | $8.9M | 2.40% | 24,019 | 减持 |
| 20 | COR | CENCORA INC | $8.8M | 2.37% | 31,126 | 增持 |
| 21 | NAMS | NEWAMSTERDAM PHARMA CO NV | $8.4M | 2.27% | 248,848 | 增持 |
| 22 | ABVX | ABIVAX SA | $7.8M | 2.09% | 58,170 | 增持 |
| 23 | INCY | INCYTE CORP | $6.5M | 1.74% | 56,953 | 增持 |
| 24 | IRTC | IRHYTHM TECHNOLOGIES INC | $6.4M | 1.73% | 54,102 | 增持 |
| 25 | BSX | BOSTON SCIENTIFC | $6.2M | 1.68% | 146,381 | 增持 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR